News - Zhongshan Wanhan Pharmaceuticals Co., Ltd

WANHAN PHARMACEUTICAL COMPANY: Sodium Hyaluronate Eye Drops - 0.3% (5ml: 15mg) has been formally approved.
WANHAN PHARMACEUTICAL COMPANY: Moxifloxacin Hydrochloride Eye Drops (Preservative-Free and Single-Dose) - 0.4ml/Unit has been officially approved.
WANHAN PHARMACEUTICAL COMPANY: Levofloxacin Eye Drops (Preservative-Free and Single-Dose) - 0.4ml/Unit has been formally approved.
2024 Zhongshan Cuiheng Island Marathon: Striving for Excellence and Pushing Forward.
WANHAN PHARMACEUTICAL COMPANY: Congratulations on the successful approval of 2% and 5% Minoxidil Topical Solution.
WANHAN PHARMACEUTICAL COMPANY: Hydrobromide Vortioxetine API has been authorized.
WANHAN PHARMACEUTICAL COMPANY: Statement regarding the employment status of our sales staff.
WANHAN PHARMACEUTICAL COMPANY: Bromfenac Sodium API has successfully upgraded to Class A.

Contact Us

Foreign Trade Email：

Foreign-Trade@whpt.com.cn

Foreign-Trade1@whpt.com.cn

Foreign Trade：

+86 139-2498-2439 (WhatsApp，WeChat)
+86 189-8859-3463

Copyright @ 2023: Zhongshan Wanhan Pharmaceutical Co., Ltd.